Advertisement
Singapore markets open in 4 hours 43 minutes

  • Straits Times Index

    3,313.48
    +8.49 (+0.26%)
     

  • S&P 500

    5,303.27
    +6.17 (+0.12%)
     

  • Dow

    40,003.59
    +134.19 (+0.34%)
     

  • Nasdaq

    16,685.97
    -12.33 (-0.07%)
     

  • Bitcoin USD

    66,280.10
    -653.78 (-0.98%)
     

  • CMC Crypto 200

    1,349.71
    -24.13 (-1.76%)
     

  • FTSE 100

    8,420.26
    -18.39 (-0.22%)
     

  • Gold

    2,419.80
    +2.40 (+0.10%)
     

  • Crude Oil

    80.00
    -0.06 (-0.07%)
     

  • 10-Yr Bond

    4.4200
    +0.0430 (+0.98%)
     

  • Nikkei

    38,787.38
    -132.92 (-0.34%)
     

  • Hang Seng

    19,553.61
    +177.11 (+0.91%)
     

  • FTSE Bursa Malaysia

    1,616.62
    +5.51 (+0.34%)
     

  • Jakarta Composite Index

    7,317.24
    -7,246.70 (-49.76%)
     

  • PSE Index

    6,618.69
    -9.51 (-0.14%)
     

Amgen surges over confidence in early obesity drug results

Akiko Fujita
·Host

Shares of Amgen (AMGN) are jumping Friday morning after the company showed confidence in early results from a GLP-1 weight-loss drug that is in development to treat obesity. The pharmaceutical giant beat first-quarter revenue estimates while reporting a loss of $113 million.

Yahoo Finance Senior Health Reporter Anjalee Khemlani joins The Morning Brief to break down the latest developments from Amgen and its outlook on use cases for the drug in question, MariTide.

For more expert insight and the latest market action, click here to watch this full episode of Morning Brief.

This post was written by Nicholas Jacobino